NEORECORMON 2000IU INJ SOL ISP 6X0,3ML

What is the maximum co-payment for NEORECORMON?

If the insurance company contributes, the maximum co-payment is 743,46 Kč. The maximum pharmacy price is 1 993,50 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but only during an outpatient procedure. When dispensed on prescription, the patient always pays the full price.

Does NEORECORMON have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

1 250,04 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Přípravek je hrazen:
1. k léčbě klinicky významné anémie (s hladinou hemoglobinu nižší než 90 g/l, s vyššími hodnotami při manifestních příznacích anémie) u pacientů zařazených do dialyzačního programu, pacientů s chronickým renálním selháním, pacientů s nádorovým onemocněním po radikální cytostatické léčbě
2. k léčbě anémie u pacientů s myelodysplastickým syndromem a anémií po transplantaci kostní dřeně.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe NEORECORMON?

hematology and transfusion medicine, pediatric oncology and hematology
internal medicine
nephrology, pediatric nephrology
clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecology
pediatrics, general practice for children and adolescents

What is the composition of NEORECORMON?

Epoetin beta (16,6 mcg), močovina, chlorid sodný, polysorbát 20, dihydrát dihydrogenfosforečnanu sodného, dodekahydrát hydrogenfosforečnanu sodného, dihydrát chloridu vápenatého, glycin, leucin, isoleucin, threonin, kyselina glutamová, fenylalanin, voda pro injekci (0,3 ml). More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to NEORECORMON?

The medicine belongs to ATC group B03XA01 – ERYTROPOETIN. Medicines with the same active substance can be found here.

Who manufactures NEORECORMON?

Roche Registration GmbH, Grenzach-Wyhlen (D)

Is the medicine in shortage?

The latest report from the manufacturer is from 1. 12. 2025. Production was terminated with effect from 1. 12. 2025. The manufacturer lists medicines with the following code as a potential substitute:
The product has no substitute listed.Note provided: Lék nahraditelný jinými léčivy ze skupiny erytropoetinů – dle uvážení lékaře.